APPY Share Price

Open 4.00 Change Price %
High 4.24 1 Day -0.35 -7.95
Low 3.71 1 Week 1.12 38.23
Close 4.05 1 Month 1.64 68.05
Volume 322719 1 Year 3.74 1206.45
52 Week High 6.65
52 Week Low 0.00
APPY Important Levels
Resistance 2 4.54
Resistance 1 4.34
Pivot 4.00
Support 1 3.76
Support 2 3.56
NASDAQ USA Most Active Stocks
SIRI 4.30 -5.49%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
QQQ 115.70 0.20%
WRES 0.09 0.00%
More..
NASDAQ USA Top Gainers Stocks
QKLS 0.21 110.00%
LOCM 0.09 50.00%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
PERF 1.90 22.58%
ASNA 7.01 20.24%
SBSA 4.60 17.95%
CEMP 7.55 15.27%
XXIA 15.55 14.76%
More..
NASDAQ USA Top Losers Stocks
PTIX 0.00 -100.00%
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
AMCF 0.03 -50.00%
VALV 0.03 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
RITT 0.06 -45.45%
More..

AspenBio Pharma, Inc. (NASDAQ: APPY)

APPY Technical Analysis 4
As on 2nd Dec 2016 APPY Share Price closed @ 4.05 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 2.44 & Buy for SHORT-TERM with Stoploss of 2.92 we also expect STOCK to react on Following IMPORTANT LEVELS.
APPY Target for December
1st Target up-side 3.42
2nd Target up-side 3.71
3rd Target up-side 4.01
1st Target down-side 2.58
2nd Target down-side 2.29
3rd Target down-side 1.99
APPY Other Details
Segment EQ
Market Capital 20371508.00
Sector Healthcare
Industry Diagnostic Substances
Offical website http://www.venaxis.com
APPY Address
APPY
1585 South Perry Street
Castle Rock, CO 80104
United States
Phone: 303-794-2000
Fax: 303-798-8332
APPY Latest News
Market Focus: Watching Shares of Venaxis, Inc. (NASDAQ:APPY)   Wall Street Beacon   - 30th Nov 16
Watching the Levels: Venaxis, Inc. (NASDAQ:APPY)   Business Daily Leader   - 29th Nov 16
Quick Review on Trend Indicator Levels: Venaxis Inc. (APPY)   MicroCap Wired   - 29th Nov 16
Venaxis, Inc. (NASDAQ:APPY) Quarterly EPS From Continuing Operations Stands At ...   Equities Focus   - 28th Nov 16
Venaxis Inc. (APPY) Stake Owned by Barry Honig   DailyQuint   - 10th Nov 16
Venaxis Announces Acquisition of BiOptix   PR Newswire (press release)   - 14th Sep 16
Venaxis Announces Transaction with Strand Life Sciences   PR Newswire (press release)   - 27th Jan 16
INVESTOR ALERT: Class Action Lawsuit Against Venaxis, Inc. Announced By Glancy ...   Business Wire (press release)   - 18th Feb 15
AspenBio Pharma Changes Company Name to Venaxis, Inc.   PR Newswire (press release)   - 13th Dec 12
Venaxis Inc. APPY (US: Nasdaq)   Wall Street Journal   - 11th Feb 11
Interactive Technical Analysis Chart AspenBio Pharma, Inc. ( APPY NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on AspenBio Pharma, Inc.
APPY Business Profile
Venaxis, Inc., formerly AspenBio Pharma, Inc., is focused on products that addresses unmet human diagnostic needs. The Company is developing a multi-marker blood test panel, APPY1, which is focused to be used by emergency department and urgent care physicians to aid them in the evaluation of possible appendicitis in children, adolescent and young adult patients (ages 2-20) that present with abdominal pain. As on December 31, 2012, the Company’s research and development activities are focused primarily on a human acute appendicitis blood-based test. APPY1 is a multi-marker blood test panel of biomarkers consisting of the Company’s patented MRP 8/14 (also known as S100A8/A9 or calprotectin) and C-reactive protein (CRP), along with White Blood Cell count (WBC). These results are displayed on the display screen and are also included on a patient print-out from the APPY reader, which is a small bioanalyzer (instrument or reader)